Results 141 to 150 of about 19,471 (205)

Pharmacokinetics in the Fontan circulation: a multi-organ puzzle. [PDF]

Eur Heart J Cardiovasc Pharmacother
Vlachakis PK, Drakopoulou M, Theofilis P, Karakasis P, Leontsinis I, Tsioufis K, Toutouzas K.   +6 more
europepmc   +1 more source

BACH2 links β1-adrenergic receptor/β-arrestin1 signaling to MIAT to inhibit cardiac fibroblast activation and cardiomyocyte apoptosis. [PDF]

Cell Death Discov
Moukette B, Teoh JP, Hashmi WJ, Kawaguchi S, Aonuma T, Moustapha H, Welc SS, Conway SJ, Liangpunsakul S, Yang L, Desai AA, Kim IM.   +11 more
europepmc   +1 more source

Recent Advances in the Diagnosis and Management of Clinically Significant Portal Hypertension in Liver Cirrhosis: A Clinical Review. [PDF]

Biomedicines
Schumacher JC, Leutiger J, Martin A, Demir M, Neumann-Haefelin C, Kasper P.   +5 more
europepmc   +1 more source

ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. [PDF]

Arq Gastroenterol
Moreno MOA, Paz CLDSL, Rodrigues MAN, Andrade ACD, Dezan MGF, Cavalcante LN, Lyra AC.   +6 more
europepmc   +1 more source

Ten-year progression of Caroli's disease with portal hypertension despite endoscopic and pharmacological therapy: Implications for liver transplantation-A case report. [PDF]

SAGE Open Med Case Rep
Meng H, Xie R, Yang C.
europepmc   +1 more source

The efficacy of carvedilol in improving cardiac function and survival in patients with anthracycline-induced cardiotoxicity: a comprehensive systematic review and meta-analysis. [PDF]

Int J Cardiol Heart Vasc
Abbasi SUAM, Bhagwan R, Rehman A, Malik N, Khaskheli SA, Rajpar NA, Nabi R, Basra AA, Meghwar S, Ahmed R, Singh K.   +10 more
europepmc   +1 more source

A Comprehensive Review on the Efficacy of Antihypertensives in Patients With End-Stage Renal Disease. [PDF]

Int J Hypertens
Akele O, Asogwa N, Wahbah Makhoul G, El-Gharib K, Ling J, Agarwal A, Agberien V, Pokima N, Gut T, El-Sayegh S.   +9 more
europepmc   +1 more source

Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease. [PDF]

Clin Kidney J
Han SH, Kim M, Lee J, Han SY.
europepmc   +1 more source

Age-Stratified Mortality Outcomes Associated with Nonselective Beta-Blocker Use in Patients with Decompensated Cirrhosis. [PDF]

J Clin Med
Nawaz A, Kaur A, Chaar A, Aswath G, Goren I, John S.   +5 more
europepmc   +1 more source